Handa Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 2/6
Handa Pharmaceuticals is a dividend paying company with a current yield of 1.72% that is well covered by earnings.
Key information
1.7%
Dividend yield
-15.9%
Buyback Yield
| Total Shareholder Yield | -14.2% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$1.000 |
| Payout ratio | 31% |
Recent dividend and buyback updates
No updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 6620's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 6620's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Handa Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6620) | 1.7% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast (6620) (up to 3 years) | n/a |
Notable Dividend: 6620's dividend (1.72%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.74%).
High Dividend: 6620's dividend (1.72%) is low compared to the top 25% of dividend payers in the TW market (4.48%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30.8%), 6620's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (19%), 6620's dividend payments are well covered by cash flows.